4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-22-000156
EVP, Quality & Ethics, and CPL acquired 96,310 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Glessner Coleen EVP, Quality & Ethics, and CPL | 2022-12-09 | Grant or award | +24,078 | 35,904 | D: show line 1 in the form | ||
| Glessner Coleen EVP, Quality & Ethics, and CPL | 2022-12-09 | Grant or award | +72,232 | 108,136 | D: show line 2 in the form |
Loading xslF345X03/wf-form4_167096997706667.xml…